Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VGT vs GSK✓SelectedUSD · GSKVGT vs GSK performance historyLatest closeAs of-3.02%11/16
Stock and ETF performance explorer

VGT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+96.4%
GSK return
+46.9%
Excess return
+49.5%
Maximum drawdown
-35.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%-0.1%-2.9%-3.0%
7D-3.7%-1.3%-2.4%-3.6%
30D-9.3%+2.7%-12.0%-9.5%
3M-11.9%+2.7%-14.6%-12.2%
6M-4.6%+3.3%-8.0%-5.3%
YTD+14.8%+6.5%+8.4%+13.2%
1Y+14.6%+10.7%+3.9%+12.2%
3Y+92.3%+64.4%+27.9%+71.2%
5Y+96.4%+46.7%+49.7%+65.4%
All+96.4%+46.9%+49.5%+65.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling